Compared to Estimates, MacroGenics (MGNX) Q2 Earnings: A Look at Key Metrics
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
MacroGenics (MGNX) reported $10.8 million in revenue for the quarter ended June 2024, representing a year-over-year decline of 17.8%. EPS of -$0.89 for the same period compares to -$0.36 a year ago.
:max_bytes(150000):strip_icc():format(jpeg)/PropertyValuation-4ecdfe3a87144fe998087ef433f49c13.jpeg "Is There a Gender Gap in Home Equity Loans?")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1346781100-2724c28da6b2479b88db9d1337ebe926.jpg "Buy Now, Pay Later or Rent-to-Own: Which Is the Smarter Way to Pay for Purchases?")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1917868586-d64880817bca4098bc8be36bbd17a4e9.jpg "Should You Trade Options on Spot Bitcoin ETFs?")